Accustem Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Accustem Sciences generated cash of -$1,806,053, which is less than the previous year. Cash used in financing activities reached the amount of $2,551,030 last year. Net change in cash is therefore $733,978.
Cash Flow
| 2021 | 0 | 0 | 0 |
|---|---|---|---|
| 2022 | -1.80M | -10.99K | 2.55M |
ACUT Cash Flow Statement (2021 – 2022)
| 2022 | 2021 | |
|---|---|---|
Cash at beginning of period | 0 | 0 |
Operating activities | ||
Net income | -3.74M | 0 |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 3.32K | 0 |
Stock-based compensation expense | 133.88K | 0 |
| Deferred income tax benefit | 133.88K | 0 |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | 0 | 0 |
Inventories | 0 | 0 |
Accounts payable | -76.84K | 0 |
Cash generated by operating activities | -1.80M | 0 |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | -10.99K | 0 |
Financing activities | ||
Common Stock Issued | 2.67M | 0 |
Payments for dividends | 0 | 0 |
Repurchases of common stock | 0 | 0 |
Repayments of term debt | 0 | 0 |
Cash used in financing activities | 2.55M | 0 |
Net Change In Cash | 733.97K | 0 |
Cash at end of period | 733.97K | 0 |
| Data source | Data source |